Cite
HARVARD Citation
Tsai, H. et al. (2022). Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series. Journal of international medical research. 50 (7), p. . [Online].